Wenjie Tao, Ph.D. - Publications

Affiliations: 
2008-2013 Chemistry Shanghai Institute of Organic Chemistry, PR China 
 2014-2017 Chemistry University of Tokyo, Bunkyō-ku, Tōkyō-to, Japan 
 2017- Chemistry Ohio State University, Columbus, Columbus, OH 

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Tao W, Bower JK, Moore CE, Zhang S. Dicopper μ-Oxo, μ-Nitrosyl Complex from the Activation of NO or Nitrite at a Dicopper Center. Journal of the American Chemical Society. PMID 31244169 DOI: 10.1021/jacs.9b03635  0.4
2019 Han Y, Gu Z, Wu J, Huang X, Zhou R, Shi C, Tao W, Wang L, Wang Y, Zhou G, Li J, Zhang Z, Sun S. Repurposing Ponatinib as a Potent Agent against Mutant Melanomas. Theranostics. 9: 1952-1964. PMID 31037149 DOI: 10.7150/thno.30890  0.64
2019 Zhou R, Shi C, Tao W, Li J, Wu J, Han Y, Yang G, Gu Z, Xu S, Wang Y, Wang L, Wang Y, Zhou G, Zhang C, Zhang Z, et al. Analysis of mucosal melanoma whole-genome landscapes reveals clinically relevant genomic aberrations. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30782616 DOI: 10.1158/1078-0432.CCR-18-3442  0.64
2018 Wang D, Tao W, Zhang X, You P, Mu X, Cao J, Li X, Wang L. [Blockage of mTOR signaling pathway by homoharringtonine inhibits proliferation and induces apoptosis of HT29 human colorectal tumor cells]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi = Chinese Journal of Cellular and Molecular Immunology. 34: 346-353. PMID 29973326  0.6
2017 Sun S, Wang Y, Zhou R, Deng Z, Han Y, Han X, Tao W, Yang Z, Shi C, Hong D, Li J, Shi D, Zhang Z. Targeting and Regulating of an Oncogene via Nanovector Delivery of MicroRNA using Patient-Derived Xenografts. Theranostics. 7: 677-693. PMID 28255359 DOI: 10.7150/thno.16357  0.64
Show low-probability matches.